Results 1 to 10 of about 40,857 (208)

Respiratory Syncytial Virus (RSV) Update

Viruses, 2022
Since the initial identification of respiratory syncytial virus (RSV) in 1956, much has been learned about the epidemiological impact and clinical manifestations of RSV infections [...]
Leonard R. Krilov, Norbert J. Roberts
openaire   +4 more sources

Pathobiology of Respiratory Syncytial Virus (RSV) [PDF]

Vaccines, 2020
Respiratory Syncytial Virus (RSV) is the leading cause of lower respiratory tract illness in infants and affects the elderly and the immune-compromised [...]
Ralph A. Tripp, Paul S. McNamara
openaire   +5 more sources

Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication

Viruses, 2022
RNA viruses like SARS-CoV-2, influenza virus, and respiratory syncytial virus (RSV) are dependent on host genes for replication. We investigated if probenecid, an FDA-approved and safe urate-lowering drug that inhibits organic anion transporters (OATs) has prophylactic or therapeutic efficacy to inhibit RSV replication in three epithelial cell lines ...
Jackelyn Murray, Harrison Bergeron, Ralph A. Tripp   +2 more
exaly   +4 more sources

Modeling household dynamics on Respiratory Syncytial Virus (RSV) [PDF]

PLOS ONE, 2019
Respiratory Syncytial Virus (RSV) is the most common cause of respiratory tract infection in infants and children and shows increasing trend among elderly people worldwide. In many developing country settings, population and household structures have gone through some significant changes in the past decades, namely fewer births, more elderly population,
Mahikul, W, White, L, Poovorawan, K, Soonthornworasiri, N, Sukontamarn, P, Chanthavilay, P, F Medley, G, Pan-Ngum, W   +7 more
openaire   +4 more sources

Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)

Pathogens, 2023
Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract disease, especially in young children. Despite its global impact on healthcare, related to its high prevalence and its association with significant morbidity, the current therapy is still mostly supportive.
Dvir Gatt, Isaac Martin, Rawan AlFouzan, Theo J. Moraes   +3 more
openaire   +3 more sources

Respiratory Syncytial Virus (RSV)

Respiratory syncytial virus (RSV) is a common respiratory virus that can cause mild to severe illness in people of all ages. The most common symptoms of an RSV infection are cough, runny nose, and fever. However, RSV can also cause more serious complications, such as tracheobronchitis, bronchiolitis, pneumonia, and apnea.
openaire   +2 more sources

Polymyalgia rheumatica following respiratory syncytial virus (RSV) vaccination

European Journal of Case Reports in Internal Medicine
Introduction: Polymyalgia rheumatica (PMR) is a chronic inflammatory disorder that causes stiffness and pain in the proximal joints, including the shoulders, hips and neck. The exact cause of polymyalgia rheumatica is yet to be fully understood, but research suggests that both genetic and environmental factors may contribute to it.
Mohamad El Labban, Stevan Oluic, Hussein Guleid, Mohamed Hassan, Rawan Diab, Mohamad Ali Rida   +5 more
openaire   +3 more sources

A comprehensive look at Respiratory Syncytial Virus (RSV): from pathogenesis to prevention. [PDF]

Trop Dis Travel Med Vaccines
Salahi Ardekani O, Hasannezhad P, Goudarzi Y, Letafati A, Taghiabadi Z, Bahari M, Nayerain Jazi N, Qaraee Najafabadi A, Shatizadeh Malekshahi S.   +8 more
europepmc   +1 more source

Advancements in Respiratory Syncytial Virus (RSV) Prevention and Treatment in Pediatrics. [PDF]

J Pediatr Pharmacol Ther
Fly JH, Stultz JS, Eiland LS.
europepmc   +1 more source

Respiratory Syncytial Virus (RSV)

, 2015
Walsh, Edward E., Hall, Caroline Breese
openaire   +1 more source